126 related articles for article (PubMed ID: 24246868)
1. [Application of DNA quantitative cytology in cervical cancer screening].
Zhong PP; Gu YQ; Wang J; Zhou QL; Wang AC; Sun XF
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):469-70. PubMed ID: 24246868
[No Abstract] [Full Text] [Related]
2. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
3. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
4. Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests.
Franceschi S; Clifford GM
J Natl Cancer Inst; 2005 Jun; 97(12):938-9; author reply 939-41. PubMed ID: 15956659
[No Abstract] [Full Text] [Related]
5. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities.
Fröberg M; Johansson B; Hjerpe A; Andersson S
Br J Cancer; 2008 Aug; 99(4):563-8. PubMed ID: 18682715
[TBL] [Abstract][Full Text] [Related]
7. Could HPV testing become the sole primary cervical screening test?
Sasieni P; Cuzick J
J Med Screen; 2002; 9(2):49-51. PubMed ID: 12133918
[No Abstract] [Full Text] [Related]
8. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
[TBL] [Abstract][Full Text] [Related]
9. Re: Have we resolved how to triage equivocal cervical cytology?
Arbyn M; Dillner J; Van Ranst M; Buntinx F; Martin-Hirsch P; Paraskevaidis E
J Natl Cancer Inst; 2004 Sep; 96(18):1401-2; author reply 1402. PubMed ID: 15367574
[No Abstract] [Full Text] [Related]
10. Human Papillomavirus DNA detection for cervical cancer screening.
Press RD
Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
[No Abstract] [Full Text] [Related]
11. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
[TBL] [Abstract][Full Text] [Related]
12. Have we resolved how to triage equivocal cervical cytology?
Solomon D; Schiffman M
J Natl Cancer Inst; 2004 Feb; 96(4):250-1. PubMed ID: 14970266
[No Abstract] [Full Text] [Related]
13. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
14. [The usefulness of p16INK4a in cytological screening of cervical carcinoma].
Li M; Cao J; Wang NP; Li LY; Li L; Qiao YL; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):674-7. PubMed ID: 17274373
[TBL] [Abstract][Full Text] [Related]
15. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
Ogilvie GS; Krajden M; van Niekerk DJ; Martin RE; Ehlen TG; Ceballos K; Smith LW; Kan L; Cook DA; Peacock S; Stuart GC; Franco EL; Coldman AJ
Br J Cancer; 2012 Dec; 107(12):1917-24. PubMed ID: 23169286
[TBL] [Abstract][Full Text] [Related]
16. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
[TBL] [Abstract][Full Text] [Related]
17. [Role of p16INK4a as a biomarker in liquid-based cervical cytology screening].
Xu T; Lu HJ; He YF
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):211-4. PubMed ID: 18756939
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization.
Nishimura M; Miyatake T; Nakashima A; Miyoshi A; Mimura M; Nagamatsu M; Ogita K; Yokoi T
Asian Pac J Cancer Prev; 2015; 16(18):8145-7. PubMed ID: 26745052
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]